Quality statement 3: Staging (rectal cancer)

Quality statement

People with rectal cancer are offered contrast-enhanced computed tomography (CT) of the chest, abdomen and pelvis to determine the stage of the disease, and pelvic magnetic resonance imaging (MRI) to assess the risk of local recurrence.

Quality measure

Structure: Evidence of local arrangements to ensure people with colorectal cancer are offered contrast-enhanced CT of the chest, abdomen and pelvis to determine the stage of the disease, and pelvic MRI to assess the risk of local recurrence.

Process: Proportion of people with rectal cancer who receive contrast-enhanced CT of the chest, abdomen and pelvis to determine the stage of the disease, and pelvic MRI to assess the risk of local recurrence.

Numerator – the number of people in the denominator who receive contrast-enhanced CT of the chest, abdomen and pelvis to determine the stage of the disease, and pelvic MRI to assess the risk of local recurrence.

Denominator – the number of people with rectal cancer without contraindications to CT of the chest, abdomen and pelvis or pelvic MRI.

What the quality statement means for each audience

Service providers ensure systems are in place for people with rectal cancer to be offered contrast-enhanced CT of the chest, abdomen and pelvis to determine the stage of the disease, and pelvic MRI to assess the risk of local recurrence.

Healthcare professionals ensure they offer people with rectal cancer contrast-enhanced CT of the chest, abdomen and pelvis to determine the stage of the disease, and pelvic MRI to assess the risk of local recurrence.

Commissioners ensure they commission services that offer people with rectal cancer contrast-enhanced CT of the chest, abdomen and pelvis to determine the stage of the disease, and pelvic MRI to assess the risk of local recurrence.

People with rectal cancer are offered a CT scan of the chest, abdomen and pelvis to estimate the spread of the disease, and an MRI scan to assess the risk of the cancer returning.

Source guidance

NICE clinical guideline 131 recommendations 1.1.2.1 and 1.1.2.2 (key priorities for implementation).

Data source

Structure: Local data collection.

Process: Local data collection. The National Bowel Cancer Audit records CT scan results, classified as normal liver, liver metastases or liver uncertain, and also records MRI scans. Also contained within NICE audit support for colorectal cancer (NICE clinical guideline 131): Staging, criteria 1 and 2.